Vestcor Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vestcor Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$608
+10.5%
13,211
+38.0%
0.02%
+10.0%
Q2 2023$550
+2.2%
9,571
-33.3%
0.02%0.0%
Q1 2023$538
+33.8%
14,3550.0%0.02%
+33.3%
Q4 2022$402
-99.9%
14,3550.0%0.02%0.0%
Q3 2022$403,000
-4.5%
14,355
+18.3%
0.02%
-6.2%
Q2 2022$422,00012,1320.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders